Endoscope-Maker Olympus Expects to Settle U.S. Claims Over Marketing

Dr. David Feinberg, president of the UCLA Health System, speaks at a news conference outside Ronald Reagan Medical Center in Westwood on Feb. 19. (Damian Dovarganes / Associated Press)

Dr. David Feinberg, president of the UCLA Health System, speaks at a news conference outside Ronald Reagan Medical Center in Westwood on Feb. 19. (Damian Dovarganes / Associated Press)

Olympus Corp., a manufacturer of endoscopes, has set aside nearly $450 million for a possible settlement of a federal investigation into its marketing of medical products.

The company did not disclose any further details except to say that the focus is on possible infractions that prohibit companies from paying kickbacks to doctors. According to the LA Times:

In recent months, Olympus has come under harsh criticism for failing to quickly warn American hospitals that one of its medical scopes is extremely difficult to clean. The device known as a duodenoscope has been linked to outbreaks at hospitals across the country that have sickened dozens of patients with antibiotic-resistant superbugs.

At UCLA Ronald Reagan Medical Center, eight patients were sickened and three died. Another outbreak at Cedars Sinai Medical Center sickened four patients. Both hospitals say they followed the manufacturer’s instructions in cleaning the intricate device but it still transferred bacteria from patient to patient.

Read more here: http://www.latimes.com/business/la-fi-olympus-probe-20150527-story.html

For more on the outbreaks, click here: http://www.latimes.com/business/la-fi-ucla-superbug-sg-storygallery.html

*Disclaimer: The views and opinions on this blog are those of the author. Nothing contained in this weblog is intended as legal advice. This weblog was created to provide general information, opinions of the author and general musings. Accessing this website is not a consultation for legal advice or services and this weblog does not create an attorney-client relationship.

 

Leave a Reply

Your email address will not be published. Required fields are marked *